Results 181 to 190 of about 35,000 (274)

From Screening to Strategy: Targeted Carbapenem-Resistant Enterobacteriaceae (CRE) Infection Prediction After Endoscopic Retrograde Cholangiopancreatography (ERCP). [PDF]

Infect Drug Resist
Wang J, Su K, Wang S, Yang Y.
europepmc   +1 more source

Cost-effectiveness analysis of ceftazidime avibactam versus colistin in carbapenem-resistant enterobacteriaceae in Iran. [PDF]

Cost Eff Resour Alloc, 2023
Goudarzi Z, Danayi F, Keshavarz K, Gholami A.   +3 more
europepmc   +1 more source

Aminoglycoside Susceptibility Agreement between an Automated System and Broth Microdilution for Carbapenem-resistant Enterobacteriaceae [PDF]

, 2017
Brandon Kulengowski, Matthew Brignola, Chanah Gallagher, David S. Burgess   +3 more
openalex   +1 more source

Daidzein-Decorated Gold Nanoparticles as a Novel Antimicrobial Strategy Against Carbapenem-Resistant Enterobacteriaceae. [PDF]

Int J Nanomedicine
Pan J, Zhang J, Hu P, Yao Z, Zhang X, Zhou T, Shen M.   +6 more
europepmc   +1 more source

EFSA BIOHAZ Panel (EFSA Panel on Biological Hazards), 2013. Scientific Opinion on Carbapenem resistance in food animal ecosystems [PDF]

, 2014

core   +1 more source

Carbapenem-Resistant Enterobacteriaceae (CRE) in Children with Cancer: The Impact of Rapid Diagnostics and Targeted Colonization Strategies on Improving Outcomes. [PDF]

Microorganisms
Madney Y, Mahfouz S, Bayoumi A, Hassanain O, Hassanain O, Sayed AA, Jalal D, Lotfi M, Tolba M, Ziad GA, Elanany M, Hashem M, Taha G, Shalaby L, Elhaddad A.   +14 more
europepmc   +1 more source

Pneumonia and Renal Replacement Therapy Are Risk Factors for Ceftazidime-Avibactam Treatment Failures and Resistance among Patients with Carbapenem-Resistant Enterobacteriaceae Infections [PDF]

, 2018
Ryan K. Shields, M. Hong Nguyen, Liang Chen, Ellen G. Press, Barry N. Kreiswirth, Cornelius J. Clancy   +5 more
openalex   +1 more source

Incidence and risk factors of active carbapenem-resistant enterobacteriaceae surveillance in hematology patients: a propensity score matching study. [PDF]

Front Microbiol
Chen S, Fan J, Xiao T, Ren J, Zhu H, Kong H, Chen D, Xu J, Ye C, Sun J, Hu C, Zheng X, Li J, Yang X, Chen Z, Hu J, Yang T.   +16 more
europepmc   +1 more source

Antibiotics promote intestinal growth of carbapenem-resistant Enterobacteriaceae by enriching nutrients and depleting microbial metabolites. [PDF]

Nat Commun, 2023
Yip AYG, King OG, Omelchenko O, Kurkimat S, Horrocks V, Mostyn P, Danckert N, Ghani R, Satta G, Jauneikaite E, Davies FJ, Clarke TB, Mullish BH, Marchesi JR, McDonald JAK.   +14 more
europepmc   +1 more source

Ceftazidime/avibactam versus standard-of-care agents against carbapenem-resistant Enterobacteriaceae harbouring blaKPC in a one-compartment pharmacokinetic/pharmacodynamic model [PDF]

, 2018
Katie E. Barber, Jason M. Pogue, Henderson D. Warnock, Robert A. Bonomo, Keith S. Kaye   +4 more
openalex   +1 more source